LOGIN  |  REGISTER
Compass Therapeutics

Medical Facilities Announces Results of 2024 Annual Meeting of Shareholders

May 09, 2024 | Last Trade: C$15.63 0.08 0.51

TORONTO, May 9, 2024 /CNW/ - Medical Facilities Corporation (TSX: DR) ("Medical Facilities", "MFC" or the "Corporation") announced that the nominees listed in the management information circular for the 2024 Annual Meeting of Shareholders (the "Meeting") held on May 9, 2024 via online webcast were elected as directors of the Corporation.

Detailed results of the votes by proxy and ballot for the election of directors are set out below.

Nominee

Votes
For

% of Votes
For

Votes
Withheld

% of Votes
Withheld

Yanick Blanchard

6,600,999

99.32 %

45,420

0.68 %

Erin S. Enright

6,606,241

99.40 %

40,178

0.60 %

Michael V. Gisser

6,283,088

94.53 %

363,331

5.47 %

Jason P. Redman

6,595,290

99.23 %

51,129

0.77 %

Reza Shahim

6,586,898

99.10 %

59,521

0.90 %

Adina G. Storch

6,597,863

99.27 %

48,556

0.73 %

At the Meeting, the shareholders of the Corporation also approved the appointment of Raymond Chabot Grant Thornton LLP as auditors of the Corporation and authorized the board of directors of the Corporation to fix their remuneration, with 99.63% of the votes in favour.

About Medical Facilities Corporation

Medical Facilities, in partnership with physicians, owns a portfolio of highly rated, high-quality surgical facilities in the United States. MFC's ownership includes controlling interest in four specialty surgical hospitals located in Arkansas, Oklahoma, and South Dakota, and an ambulatory surgery center ("ASC") located in California. The specialty surgical hospitals perform scheduled surgical, imaging, diagnostic and other procedures, including primary and urgent care, and derive their revenue from the fees charged for the use of their facilities. The ASC specializes in outpatient surgical procedures, with patient stays of less than 24 hours. For more information, please visit www.medicalfacilitiescorp.ca.

Caution concerning forward-looking statements

Statements made in this news release, other than those concerning historical financial information, may be forward-looking and therefore subject to various risks and uncertainties.  Some forward-looking statements may be identified by words like "may", "will", "anticipate", "estimate", "expect", "intend", or "continue" or the negative thereof or similar variations. Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements. Factors that could cause results to vary include those identified in Medical Facilities' filings with Canadian securities regulatory authorities such as legislative or regulatory developments, intensifying competition, technological change and general economic conditions. All forward-looking statements presented herein should be considered in conjunction with such filings. Medical Facilities does not undertake to update any forward-looking statements; such statements speak only as of the date made.

Stock Quote

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB